MIRA INFORM REPORT

 

 

Report Date :

11.01.2014

 

IDENTIFICATION DETAILS

 

Name :

P.T. KOLOSAL PRATAMA

 

 

Registered Office :

Ruko Graha Mas Pemuda, Blok AC No.15-16, Jl. Pemuda, Pulogadung, Jakarta Timur 13220

 

 

Country :

Indonesia

 

 

Date of Incorporation :

14.02.2002

 

 

Com. Reg. No.:

AHU-AH.01.10-22941

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Trading, Import and Distribution of Active Pharmaceuticals Ingredients, Natural Active Pharmaceutical, Natural Plant Extracts Standardized, Cosmetic & Personal Care, Nutraceuticals, Mineral and Additives.

 

 

No. of Employees :

20

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

Indonesia

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDONESIA - ECONOMIC OVERVIEW

 

Indonesia, a vast polyglot nation, grew more than 6% annually in 2010-12. The government made economic advances under the first administration of President YUDHOYONO (2004-09), introducing significant reforms in the financial sector, including tax and customs reforms, the use of Treasury bills, and capital market development and supervision. During the global financial crisis, Indonesia outperformed its regional neighbors and joined China and India as the only G20 members posting growth in 2009. The government has promoted fiscally conservative policies, resulting in a debt-to-GDP ratio of less than 25%, a fiscal deficit below 3%, and historically low rates of inflation. Fitch and Moody's upgraded Indonesia's credit rating to investment grade in December 2011. Indonesia still struggles with poverty and unemployment, inadequate infrastructure, corruption, a complex regulatory environment, and unequal resource distribution among regions. The government in 2013 faces the ongoing challenge of improving Indonesia''s insufficient infrastructure to remove impediments to economic growth, labor unrest over wages, and reducing its fuel subsidy program in the face of high oil prices.

 

Source : CIA

 


BASIC SEARCH

 

Name of Company :

P.T. KOLOSAL PRATAMA

 

Address :

Head Office

Ruko Graha Mas Pemuda, Blok AC No.15-16

Jl. Pemuda, Pulogadung

Jakarta Timur 13220

Indonesia

Phones             - (62-21) 470 1971 (hunting)

Fax                   - (62-21) 470 1966

Email                - kolosal@cbn.net.id

Building Area     - 5 storey

Office Space      - 240 sq. meters

Region              - Commercial

Status               - Rent

 

Date of Incorporation :

14 February 2002

 

Legal Form :

P.T. (Perseroan Terbatas) or Limited Liability Company

 

Company Reg. No. :

The Ministry of Law and Human Rights

            a.         No. C-12920 HT.01.01.TH.2002

                        Dated 15 July 2002

            b.         No. AHU-13474.AH.01.02.Tahun 2008

                        Dated 18 March 2008

            c.         No. AHU-AH.01.10-22941

                        Dated 11 June 2013

 

Company Status :

National Private Company

 

Permit by the Government Department :

            a. The Department of Finance

                NPWP No. 02.100.386.8-003.000

 

            b. The Department of Trade

                - General Importer License: 090408024

                - Registration Importer No: S-011039/TRI/BC/L/2003

 

Related/Associated Company :

Not available

 

 

CAPITAL AND OWNERSHIP

 

Capital Structure :

Authorized Capital          - Rp. 10,000,000,000.-

Issued Capital                - Rp.   3,000,000,000.-

Paid up Capital              - Rp.   3,000,000,000.-

 

Shareholders/Owners :           

            a. Mr. Dr. Asal, Apt.      - Rp. 1,950,000,000.- (65%)

     Address : Jl. Cipinang Baru Bunder No.4

                     Cipinang, Pulogadung

                     East Jakarta

 

            b. Mrs. Vonny Imelda   - Rp. 1,020,000,000.- (34%)

     Address : Jl. Cipinang Baru Bunder No.4

                     Cipinang, Pulogadung

                     East Jakarta

 

            c. Mr. Edywan  - Rp.      30,000,000.- (  1%)

     Address : Jl. Maleo XI Blok JC.2/9

                     Pondok Pucung, Tangerang

                     Banten Province

 

 

BUSINESS ACTIVITIES

 

Lines of Business :

Trading, Import and Distribution of Active Pharmaceuticals Ingredients, Natural Active Pharmaceutical, Natural Plant Extracts Standardized, Cosmetic & Personal Care, Nutraceuticals, Mineral and Additives.

 

Production Capacity :

None

 

Total Investment :

None

 

Started Operation :

2 0 0 2

 

Brand Name :

Kolosal Pratama

 

Technical Assistance :

None

 

Number of Employee :

20 persons

 

Marketing Area :

Local    - 100%

 

Main Customers :

a. Pharmaceutical Industries

b. Cosmetic and Personal Care Products Industries

c. Food and Beverage Industries

 

Market Situation :

Very Competitive

 

Main Competitors :

a. PT. Justus Kimiaraya

b. PT. Adimitra Prima Lestari

c. PT. Halim Sakti Pratama

d. PT. Kharindo Prakarsa

e. PT. Elang Kurniasakti

f.  PT. Indokemika Jayatama

 

Business Trend :

Growing

 

 

BANKER, AUDITOR & LITIGATION

 

Bankers :

            a.         P.T. Bank CENTRAL ASIA Tbk

                        Rawamangun Branch

                        Jl. Paus No. 81, Rawamangun

                        Jakarta Timur

                        Indonesia

            b.         P.T. Bank NEGARA INDONESIA Tbk

                        Pemuda Branch

                        Jl. Pemuda No. 15-16

                        Jakarta Timur

                        Indonesia

 

Auditor :

Internal Auditor

 

Litigation :

No litigation record in our database

 

 

FINANCIAL FIGURE

 

Total Sales/Revenues (estimated) :

1010 – Rp. 32.0 billion

2011 – Rp. 38.0 billion

2012 – Rp. 46.0 billion

2013 – Rp. 55.0 billion

 

 

Net Profit (estimated) :

2010 – Rp. 1.6 billion

2011 – Rp. 2.0 billion

2012 – Rp. 2.4 billion

2013 – Rp. 3.0 billion

 

Payment Manner :

Average

 

Financial Comments :

Satisfactory

 

 

KEY EXECUTIVES

 

Board of Management :

President Director                      - Mr. Drs. Asal, Apt.

Director                                     - Mr. Vonny Imelda

 

Board of Commissioners :

Commissioner                           - Mr. Edywan

 

Signatories :

President Director (Mr. Drs. Asal, Apt.) or Director (Mrs. Vonny Imelda) which must be approved by Board of Commissioner (Mr. Edywan)

 

 

CAPABILITIES

 

Management Capability :

Good

 

Business Morality :

Good

 

 

OVERALL PERFORMANCE

 

P.T. KOLOSAL PRATAMA (P.T. KP) was established in Jakarta based on Notarial Deed No. 65 dated February 14, 2002 made by Notary Yonsah Minanda, SH., notary in Jakarta with an authorized capital of  Rp 100,000,000.- issued capital of Rp 30.000.000.- entirely was paid up.  The founding shareholders of the company are Mr. Drs. Asal, Apt. (60%) and Mrs. Thio Giuliani (40%), both Indonesian entrepreneurs of Chinese extraction.  The Deed of establishment has been approved by the Minister of Justice and Human Rights in its Decision Letter No. C-12920 HT.01.01.TH.2002 dated July 15, 2002. 

 

The articles of association of the company have frequently been changed, most recently by notarial Deed No. 18 dated March 30, 2013 made by Notary Munir Syawal Pandapotan Sinaga, SH., the authorized capital was raised to Rp 10,000,000,000.- of which Rp. 3,000,000,000.- was issued and fully paid up. Since at the time, the shareholders of the company are Mr. Drs. Asal, Apt. (65%), his wife Mrs. Vonny Imelda (34%) and Mr. Edywan (1%). The capital structures and shareholder composition of P.T. SSK in details are as shown on page-3 of this report. The amendment to Deed has been approved by the Minister of Law and Human Rights of the Republic of Indonesia through Decree No. AHU-AH.01.10-22941 dated June 11, 2013.

 

P.T. KP has been in operation since 2002 in trading, import and distribution of Active Pharmaceuticals Ingredients, Natural Active Pharmaceutical, Natural Plant Extracts Standardized, Cosmetic & Personal Care, Nutraceuticals, Mineral and Additives.  Mr. Awaluddin, a marketing staff of the company explained that P.T. KP was appointed as a distributor and agent for the above products imported from several countries such as China, India, Europe, USA and also local products.   All the company's merchandize products are sold to locally such as; pharmaceutical industries, cosmetic and personal care industries, food and beverage industries and others.  We observed that P.T. KP is classified as a medium-sized company of its kind in the country of which the operation has been growing in the last three years.

 

The domestic demand for active pharmaceutical ingredient, natural active pharmaceutical, natural plant extracts, cosmetic and personal care, nutraceuticals, mineral and additives had been rising by 8% to 10% on the average per annum in the last five years in line with the rapid growth of pharmaceutical industries, cosmetic industries, food and beverage industries, etc. But, later dwindled as the global economic slowdown since October 2008, followed by tight money policy imposed by Indonesian Central Bank (Bank Indonesia) and also heated by political issue in the country. The demand growth started to awake in June 2009 in line with the amelioration of economic condition in the country.  Market competition is very tough on account of large number of other similar companies operating in the country. P.T. KP business position in this case is not too badly because it has built regular customers and extensive marketing network in Jakarta, Bekasi, Tangerang, Bogor and its surroundings.

 

Until this time P.T. KP has not been registered with Indonesian Stock Exchange, so that they shall not obliged to announce their financial statement. The management of P.T. KP is very reclusive towards outsiders and rejected to disclose its financial condition.  We observed that total sales turnover of the company in 2010 amounted to Rp. 32.0 billion increased to Rp. 38.0 billion in 2011 rose again to Rp. 46.0 billion in 2012 and to Rp 55.0 billion in 2013.  The operation in 2013 yielded an estimated net profit of at least Rp. 3.0 billion and the company has an estimated total net worth of at least Rp. 12.0 billion. So far, we did not heard that the company having been black listed by the Central Bank (Bank Indonesia). The company usually pays its debts punctually to suppliers.

 

The management of P.T. KP is led by Mr. Drs. Asal, Apt. (43) as President Director, a businessman who experienced for more than 10 years in the field of trading, import and distribution of pharmaceutical raw material, cosmetic and personal care chemicals, food ingredients, etc.  Daily operation he is assisted by his wife Mrs. Vonny Imelda (41) as Director and Mr. Edywan (35) as Commissioner.  The management is handled by experienced staff in this business, having maintained a wide business relation with private businessmen at home and abroad as well as with government sectors. So far, we did not hear that the management of the company being filed to the district court for detrimental cases or involved in any business malpractices. The company’s litigation record is clean and it has not registered with the black list of Bank of Indonesia.

 

P.T. KOLOSAL PRATAMA is sufficiently fairly good for business transaction.  However, in view of the unstable economic condition in the country we recommend to treat prudently in extending a loan to the company.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.94

UK Pound

1

Rs.102.06

Euro

1

Rs.84.31

 

 

INFORMATION DETAILS

 

Report Prepared by :

NNA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.